{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:00:52Z","timestamp":1767888052141,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.neurobiolaging.2006.04.005","type":"journal-article","created":{"date-parts":[[2006,6,12]],"date-time":"2006-06-12T20:49:43Z","timestamp":1150145383000},"page":"856-862","source":"Crossref","is-referenced-by-count":56,"title":["Gender-specific association of ATP-binding cassette transporter 1 (ABCA1) polymorphisms with the risk of late-onset Alzheimer's disease"],"prefix":"10.1016","volume":"28","author":[{"given":"Purnima Desai","family":"Sundar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleanor","family":"Feingold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan L.","family":"Minster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven T.","family":"DeKosky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Ilyas","family":"Kamboh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2006.04.005_bib1","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1056\/NEJMoa042765","article-title":"Family-based association between Alzheimer's disease and variants in UBQLN1","volume":"352","author":"Bertram","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurobiolaging.2006.04.005_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/hmg\/ddg007","article-title":"Results of a high-resolution genome screen of 437 Alzheimer's disease families","volume":"12","author":"Blacker","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurobiolaging.2006.04.005_bib3","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.mrfmmm.2004.08.017","article-title":"Genetic association analysis: lessons from the study of Alzheimers disease","volume":"573","author":"Brookes","year":"2005","journal-title":"Mutat Res"},{"key":"10.1016\/j.neurobiolaging.2006.04.005_bib4","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1023\/B:NERE.0000042217.90204.8d","article-title":"Effects of lovastatin and pravastatin on amyloid processing and inflammatory response in TgCRND8 brain","volume":"29","author":"Chauhan","year":"2004","journal-title":"Neurochem Res"},{"key":"10.1016\/j.neurobiolaging.2006.04.005_bib5","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1161\/01.CIR.103.9.1198","article-title":"Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease","volume":"103","author":"Clee","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.neurobiolaging.2006.04.005_bib6","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1126\/science.1099870","article-title":"Multiple rare alleles contribute to low plasma levels of HDL cholesterol","volume":"305","author":"Cohen","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2006.04.005_bib7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.neulet.2005.01.008","article-title":"Investigation of the effect of brain-derived neurotrophic factor (BDNF) polymorphisms on the risk of late-onset Alzheimer's disease (AD) and quantitative measures of AD progression","volume":"379","author":"Desai","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2006.04.005_bib8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s00109-003-0426-y","article-title":"The association of the R219K polymorphism in the ATP-binding cassette transporter 1 (ABCA1) gene with coronary heart disease and hyperlipidaemia","volume":"81","author":"Evans","year":"2003","journal-title":"J Mol Med"},{"key":"10.1016\/j.neurobiolaging.2006.04.005_bib9","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer disease meta analysis consortium","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2006.04.005_bib10","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1212\/WNL.59.8.1257","article-title":"Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide","volume":"59","author":"Fassbender","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.04.005_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.neurobiolaging.2006.04.005_bib12","doi-asserted-by":"crossref","first-page":"41197","DOI":"10.1074\/jbc.M407962200","article-title":"Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain","volume":"279","author":"Hirsch-Reinshagen","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurobiolaging.2006.04.005_bib13","doi-asserted-by":"crossref","first-page":"43243","DOI":"10.1074\/jbc.M508781200","article-title":"The absence of ABCA1 decreases soluble apoE levels but does not diminish amyloid deposition in two murine models of Alzheimer's disease","volume":"280","author":"Hirsch-Reinshagen","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurobiolaging.2006.04.005_bib14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000084550","article-title":"The effect of simvastatin treatment on the amyloid precursor protein and brain cholesterol metabolism in patients with Alzheimer's disease","volume":"19","author":"Hoglund","year":"2005","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.neurobiolaging.2006.04.005_bib15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/10618600.1996.10474713","article-title":"A language for data analysis and graphics","volume":"5","author":"Ihaka","year":"1996","journal-title":"J Comput Graphic. Stat."},{"key":"10.1016\/j.neurobiolaging.2006.04.005_bib16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/sj.mp.4001775","article-title":"Genetic association of ubiquilin with Alzheimer's disease and related quantitative measures","volume":"11","author":"Kamboh","year":"2006","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2006.04.005_bib17","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/humu.20012","article-title":"Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism","volume":"23","author":"Katzov","year":"2004","journal-title":"Hum Mutat"},{"key":"10.1016\/j.neurobiolaging.2006.04.005_bib18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10038-005-0341-x","article-title":"Quantitative trait loci in ABCA1 modify cerebrospinal fluid amyloid-\u03b21-42 and plasma apolipoprotein levels","volume":"51","author":"Katzov","year":"2006","journal-title":"J Hum Genet"},{"key":"10.1016\/j.neurobiolaging.2006.04.005_bib19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/hmg\/8.2.237","article-title":"A full genome scan for late onset Alzheimer's disease","volume":"8","author":"Kehoe","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurobiolaging.2006.04.005_bib20","doi-asserted-by":"crossref","first-page":"43224","DOI":"10.1074\/jbc.M504513200","article-title":"Lack of ABCA1 considerably decreases brain APOE level and increases amyloid deposition in APP23 mice","volume":"280","author":"Koldamova","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurobiolaging.2006.04.005_bib21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.atherosclerosis.2003.08.014","article-title":"Heterozygosity for ABCA1 gene mutations: effects on enzymes, apolipoproteins and lipoprotein particle size","volume":"171","author":"Kuivenhoven","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.neurobiolaging.2006.04.005_bib22","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.neulet.2004.05.047","article-title":"Association of ABCA1 with late-onset Alzheimer's disease is not observed in a case\u2013control study","volume":"366","author":"Li","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2006.04.005_bib23","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.04.005_bib24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ajmg.10183","article-title":"Full genome screen for Alzheimer disease: stage II analysis","volume":"114","author":"Myers","year":"2002","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.neurobiolaging.2006.04.005_bib25","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1388-1981(00)00157-8","article-title":"Tangier disease and ABCA1","volume":"1529","author":"Oram","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.neurobiolaging.2006.04.005_bib26","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0531-5565(00)00196-0","article-title":"Identification of novel genes in late-onset Alzheimer's disease","volume":"35","author":"Pericak-Vance","year":"2000","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.neurobiolaging.2006.04.005_bib27","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/nbdi.2000.0304","article-title":"Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model","volume":"7","author":"Refolo","year":"2000","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neurobiolaging.2006.04.005_bib28","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1023\/A:1020604610873","article-title":"Estrogen-induced regulation of the ATP-binding cassette transporter A1 (ABCA1) in mice: a possible mechanism of atheroprotection by estrogen","volume":"240","author":"Srivastava","year":"2002","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.neurobiolaging.2006.04.005_bib29","doi-asserted-by":"crossref","first-page":"40987","DOI":"10.1074\/jbc.M407963200","article-title":"ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE","volume":"279","author":"Wahrle","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurobiolaging.2006.04.005_bib30","doi-asserted-by":"crossref","first-page":"43236","DOI":"10.1074\/jbc.M508780200","article-title":"Direction of ABCA1 increases A\u03b2 deposition in the PDAPP transgenic mouse model of Alzheimers disease","volume":"280","author":"Wahrle","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurobiolaging.2006.04.005_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0009-9163.2004.00280.x","article-title":"Cholesterol at the crossroads: Alzheimer's disease and lipid metabolism","volume":"66","author":"Wellington","year":"2004","journal-title":"Clin Genet"},{"key":"10.1016\/j.neurobiolaging.2006.04.005_bib32","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0197-4580(02)00094-5","article-title":"ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease","volume":"24","author":"Wollmer","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurobiolaging.2006.04.005_bib33","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/archneur.57.10.1439","article-title":"Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors","volume":"57","author":"Wolozin","year":"2000","journal-title":"Arch Neurol"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458006001199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458006001199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T10:07:18Z","timestamp":1736417238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458006001199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0197458006001199"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2006.04.005","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}